Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
Kany S, Al-Taie C, Roselli C, Pirruccello JP, Borof K, Reinbold C, Suling A, Krause L, Reissmann B, Schnabel RB, Zeller T, Zapf A, Wegscheider K, Fabritz L, Ellinor PT, Kirchhof P. Kany S, et al. Among authors: wegscheider k. Cardiovasc Res. 2023 Aug 7;119(9):1799-1810. doi: 10.1093/cvr/cvad027. Cardiovasc Res. 2023. PMID: 37264683 Free PMC article. Clinical Trial.
Longer-Term Effects of Remote Patient Management Following Hospital Discharge After Acute Systolic Heart Failure: The Randomized E-INH Trial.
Angermann CE, Sehner S, Faller H, Güder G, Morbach C, Frantz S, Wegscheider K, Ertl G, Störk ST; INH Study Group and of the Competence Network Heart Failure. Angermann CE, et al. Among authors: wegscheider k. JACC Heart Fail. 2023 Feb;11(2):191-206. doi: 10.1016/j.jchf.2022.10.016. Epub 2023 Jan 11. JACC Heart Fail. 2023. PMID: 36718715 Free article. Clinical Trial.
Lifestyle intervention reduces risk score for cardiovascular mortality in company employees with pre-diabetes or diabetes mellitus - A secondary analysis of the PreFord randomized controlled trial with 3 years of follow-up.
Brinkmann C, Hof H, Gysan DB, Albus C, Millentrup S, Bjarnason-Wehrens B, Latsch J, Herold G, Wegscheider K, Heming C, Seyfarth M, Predel HG. Brinkmann C, et al. Among authors: wegscheider k. Front Endocrinol (Lausanne). 2023 Feb 23;14:1106334. doi: 10.3389/fendo.2023.1106334. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36909345 Free PMC article. Clinical Trial.
Patient-Reported Quality of Life After Intravenous Alteplase for Stroke in the WAKE-UP Trial.
Jensen M, Sehner S, Cheng B, Schlemm E, Quandt F, Barow E, Wegscheider K, Boutitie F, Ebinger M, Endres M, Fiebach JB, Thijs V, Lemmens R, Muir KW, Nighoghossian N, Pedraza S, Simonsen CZ, Thomalla G, Gerloff C. Jensen M, et al. Among authors: wegscheider k. Neurology. 2023 Jan 10;100(2):e154-e162. doi: 10.1212/WNL.0000000000201375. Epub 2022 Oct 27. Neurology. 2023. PMID: 36302662 Clinical Trial.
Safety and efficacy of long-term Sodium Channel Blocker therapy for Early Rhythm Control: The EAST-AFNET 4 trial.
Rillig A, Eckardt L, Borof K, Camm AJ, Crijns HJGM, Goette A, Breithardt G, Lemoine MD, Metzner A, Rottner L, Schotten U, Vettorazzi E, Wegscheider K, Zapf A, Heidbuchel H, Willems S, Fabritz L, Schnabel RB, Magnussen C, Kirchhof P. Rillig A, et al. Among authors: wegscheider k. Europace. 2024 May 4:euae121. doi: 10.1093/europace/euae121. Online ahead of print. Europace. 2024. PMID: 38702961
Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study.
Fabritz L, Chua W, Cardoso VR, Al-Taie C, Borof K, Suling A, Krause L, Kany S, Magnussen C, Wegscheider K, Breithardt G, Crijns HJGM, Camm AJ, Gkoutos G, Ellinor PT, Goette A, Schotten U, Wienhues-Thelen UH, Zeller T, Schnabel RB, Zapf A, Kirchhof P. Fabritz L, et al. Among authors: wegscheider k. Cardiovasc Res. 2024 Apr 13:cvae067. doi: 10.1093/cvr/cvae067. Online ahead of print. Cardiovasc Res. 2024. PMID: 38613511
464 results